Nantilus
The right therapy for neurological disorders : from randomized trials to clinical practice
Most neurological disorders are chronic and aging-related. With the increase of life expectancy their incidence and prevalence will grow in the decades to come, which in turn will increase the load on medical and social systems worldwide. There is thus a desperate need for successful preventive and...
Enregistré dans:
| Autres auteurs : | , |
|---|---|
| Format : | Livre |
| Langue : | anglais |
| Titre complet : | The right therapy for neurological disorders : from randomized trials to clinical practice / volume editors, E. Beghi, G. Logroscino, [et al.] |
| Publié : |
Basel :
Karger AG
, 2016 |
| Collection : | Frontiers of neurology and neuroscience (Online) ; 39 |
| Accès en ligne : |
Accès Nantes Université
Accès direct soit depuis les campus via le réseau ou le wifi eduroam soit à distance avec un compte @etu.univ-nantes.fr ou @univ-nantes.fr |
| Note sur l'URL : | Il faut cliquer sur la mention "You already have online access to this title" pour accéder au document |
| Sujets : | |
| Documents associés : | Autre format:
The right therapy for neurological disorders |
| Particularités de l'exemplaire : | Bib. numérique, Ex. 1 : Accessible sur la base Karger |
| LEADER | 04465clm a2200697 4500 | ||
|---|---|---|---|
| 001 | PPN199311587 | ||
| 003 | http://www.sudoc.fr/199311587 | ||
| 005 | 20210323094400.0 | ||
| 010 | |a 978-3-318-05865-9 |b PDF | ||
| 017 | 7 | 0 | |a 10.1159/isbn.9783318058659 |2 doi |
| 035 | |a (OCoLC)973399887 | ||
| 035 | |a KARGER_LN20_9783318058659 | ||
| 073 | 0 | |a 9783318058659 | |
| 100 | |a 20170313d2016 k y1frey0103 ba | ||
| 101 | 0 | |a eng | |
| 102 | |a CH | ||
| 105 | |a a a 001yy | ||
| 135 | |a drc|#|||m|||| | ||
| 181 | |6 z01 |c txt |2 rdacontent | ||
| 181 | 1 | |6 z01 |a i# |b xxxe## | |
| 182 | |6 z01 |c c |2 rdamedia | ||
| 182 | 1 | |6 z01 |a b | |
| 183 | 1 | |6 z01 |a ceb |2 rdacarrier | |
| 200 | 1 | |a The right therapy for neurological disorders |e from randomized trials to clinical practice |f volume editors, E. Beghi, G. Logroscino, [et al.] | |
| 214 | 0 | |a Basel |c Karger AG |d 2016 | |
| 225 | 0 | |a Frontiers of neurology and neuroscience |x 1662-2804 |v Vol. 39 | |
| 230 | |a Données textuelles | ||
| 316 | |5 441099901:69293717X |a Accessible sur la base Karger | ||
| 320 | |a Notes bibliogr. en fin de chapitres. Index | ||
| 330 | |a Most neurological disorders are chronic and aging-related. With the increase of life expectancy their incidence and prevalence will grow in the decades to come, which in turn will increase the load on medical and social systems worldwide. There is thus a desperate need for successful preventive and therapeutic measures based on randomized clinical trials (RTCs) conducted by independent organizations. This book provides a compendium relating most of the principles of reliable RTCs to specific neurological diseases. Contributed by specialized neurologists, the articles touch on important aspects of RCTs with a clear critical approach, highlighting their limitations as well as giving recommendations for their planning and conducting to address the variable genotypic and phenotypic aspects of neurological conditions. Consideration is also given to combining the clinical impact of the study results with patients values and the interests of pharmaceutical companies | ||
| 336 | |a Présentation en 19 fichiers correspondant aux différents chapitres, parties liminaires et index. Format PDF | ||
| 337 | |a Navigateur internet, lecteur de fichiers PDF ; liseuse | ||
| 410 | | | |0 123678315 |t Frontiers of neurology and neuroscience (Online) |x 1662-2804 |v 39 | |
| 452 | | | |0 196619521 |t The right therapy for neurological disorders |o from randomized trials to clinical practice |f volume editors, E. Beghi, Milan, G. Logroscino, |c Basel |n Karger |d cop. 2016 |p 1 vol. (X-168 p.) |s Frontiers of neurology and neuroscience |y 978-3-318-05864-2 | |
| 606 | |3 PPN040746437 |a Maladies du système nerveux |3 PPN038961334 |x traitement médicamenteux |2 fmesh | ||
| 606 | |3 PPN040809323 |a Essais contrôlés randomisés comme sujet |2 fmesh | ||
| 606 | |3 PPN040696782 |a Évaluation de médicament |3 PPN038961520 |x méthodes |2 fmesh | ||
| 606 | |3 PPN040816796 |a Résultat thérapeutique |2 fmesh | ||
| 606 | |3 PPN040837998 |a Médecine factuelle |3 PPN038961520 |x méthodes |2 fmesh | ||
| 606 | |3 PPN040746437 |a Maladies du système nerveux |3 PPN038961334 |x traitement médicamenteux |2 fmesh | ||
| 606 | |3 PPN040809323 |a Essais contrôlés randomisés comme sujet |2 fmesh | ||
| 606 | |3 PPN040696782 |a Évaluation de médicament |3 PPN038961520 |x méthodes |2 fmesh | ||
| 606 | |3 PPN040816796 |a Résultat thérapeutique |2 fmesh | ||
| 606 | |3 PPN040837998 |a Médecine factuelle |3 PPN038961520 |x méthodes |2 fmesh | ||
| 606 | |3 PPN027313751 |a Système nerveux |x Maladies |2 rameau | ||
| 606 | |3 PPN031453996 |a Essais cliniques des médicaments |2 rameau | ||
| 606 | |3 PPN055332153 |a Médecine basée sur les preuves |2 rameau | ||
| 676 | |a 616.8/0461 |v 23 | ||
| 680 | |a RM315 |b .R54 2016 | ||
| 686 | |a W1 |b MO568C v.39 2016 |2 usnlm | ||
| 686 | |a WL 140 |2 usnlm | ||
| 702 | 1 | |3 PPN196666988 |a Beghi |b Ettore |4 340 | |
| 702 | 1 | |3 PPN196667151 |a Logroscino |b Giancarlo |4 340 | |
| 801 | 3 | |a FR |b Abes |c 20210304 |g AFNOR | |
| 856 | 4 | |5 441099901:69293717X |u https://budistant.univ-nantes.fr/login?url=https://www.karger.com/Book/Home/271628 |z Il faut cliquer sur la mention "You already have online access to this title" pour accéder au document | |
| 915 | |5 441099901:69293717X |b KAR41-2021121 | ||
| 930 | |5 441099901:69293717X |b 441099901 |j g | ||
| 979 | |a NUM | ||
| 991 | |5 441099901:69293717X |a Exemplaire créé en masse par ITEM. le 22-03-2021 12:25 | ||
| 997 | |a NUM |b KAR41-2021121 |d NUMpivo |e DNUM |s d | ||
| 998 | |a 891467 | ||